Merck acquires Swiss biotech start-up
Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics
22-Dec-2021 -
Merck announced a strategically focused expansion of its neurology pipeline with the acquisition of the rights to develop cladribine for the treatment of generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Merck entered into an agreement to secure the global ...
acquisitions
Cladribine
myasthenia gravis
+1